Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Kimberly R. Hagel"'
Autor:
Kimberly R. Hagel, Rand Arafeh, Sydney Gang, Taylor E. Arnoff, Rebecca C. Larson, John G. Doench, Nathan D. Mathewson, Kai W. Wucherpfennig, Marcela V. Maus, William C. Hahn
Publikováno v:
Cancer Research. 83:613-625
Chimeric antigen receptor (CAR) T-cell therapy can lead to dramatic clinical responses in B-cell malignancies. However, early clinical trials with CAR T-cell therapy in non–B-cell malignancies have been disappointing to date, suggesting that tumor-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6afdd9701340fb5f0b5723b4576a2721
https://doi.org/10.1158/0008-5472.can-22-2245
https://doi.org/10.1158/0008-5472.can-22-2245
Autor:
William C. Hahn, Marcela V. Maus, Kai W. Wucherpfennig, Nathan D. Mathewson, John G. Doench, Rebecca C. Larson, Taylor E. Arnoff, Sydney Gang, Rand Arafeh, Kimberly R. Hagel
Supplemental figures 1-6
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d323d509f19bc08e631460625314320c
https://doi.org/10.1158/0008-5472.22433510.v1
https://doi.org/10.1158/0008-5472.22433510.v1
Autor:
William C. Hahn, Marcela V. Maus, Kai W. Wucherpfennig, Nathan D. Mathewson, John G. Doench, Rebecca C. Larson, Taylor E. Arnoff, Sydney Gang, Rand Arafeh, Kimberly R. Hagel
expression of Hallmark IFNγ/IFNα gene sets in HupT3 cells following TFAP4 knockout and overexpression
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11dc04f6ee4dc3dfba176df199dac5a3
https://doi.org/10.1158/0008-5472.22433501
https://doi.org/10.1158/0008-5472.22433501
Autor:
Kimberly R, Hagel, Rand, Arafeh, Sydney, Gang, Taylor E, Arnoff, Rebecca C, Larson, John G, Doench, Nathan D, Mathewson, Kai W, Wucherpfennig, Marcela V, Maus, William C, Hahn
Publikováno v:
Cancer research.
Chimeric antigen receptor (CAR) T cell therapy can lead to dramatic clinical responses in B cell malignancies. However, early clinical trials with CAR T cell therapy in non-B cell malignancies have been disappointing to date, suggesting that tumor in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::514f056370368f77803bc6d63d720116
https://pubmed.ncbi.nlm.nih.gov/36548402
https://pubmed.ncbi.nlm.nih.gov/36548402
Publikováno v:
PLoS ONE, Vol 10, Iss 7, p e0132636 (2015)
Calcium is a primary second messenger in all cells that functions in processes ranging from cellular proliferation to synaptic transmission. Proper regulation of calcium is achieved through numerous mechanisms involving channels, sensors, and buffers
Externí odkaz:
https://doaj.org/article/7235ef9a00884c03961701afeb3992f2
Publikováno v:
Trends in Cancer. 3:475-481
Integrin-mediated attachment to the extracellular matrix (ECM) is required to combat the induction of programmed cell death in a variety of distinct cell types. If cells fail to maintain proper ECM attachment, they become subject to elimination via a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5a8157f7349289a6c8584a65cd7059e
https://doi.org/10.1016/j.trecan.2017.04.009
https://doi.org/10.1016/j.trecan.2017.04.009
Publikováno v:
PLoS ONE, Vol 10, Iss 7, p e0132636 (2015)
PLoS ONE
PLoS ONE
Calcium is a primary second messenger in all cells that functions in processes ranging from cellular proliferation to synaptic transmission. Proper regulation of calcium is achieved through numerous mechanisms involving channels, sensors, and buffers
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb26fcf32c2738f7e8f76107141a8387
http://europepmc.org/articles/PMC4500412?pdf=render
http://europepmc.org/articles/PMC4500412?pdf=render
Autor:
Kelsey J. Weigel, Zachary T. Schafer, Kimberly R. Hagel, Matthew M. Champion, Luke McCormack, Meaghan Boyd
Publikováno v:
Cancer Research. 76:4087-4087
Cancer development and progression are inherently inefficient processes riddled with anti-tumorigenic obstacles. Anoikis, or apoptosis induced by detachment from the extracellular matrix (ECM), represents one prominent hindrance to cancer progression
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0f653a6515ff4698413b4278a7b140dd
https://doi.org/10.1158/1538-7445.am2016-4087
https://doi.org/10.1158/1538-7445.am2016-4087
Publikováno v:
Immunotherapy Weekly; 4/4/2023, p669-669, 1p